AR027484A1 - USEFUL FUSION PROTEIN IN THE TREATMENT OR PREVENTION OF ZOSTER HERPES AND IN THE PREVENTION OR TREATMENT OF VARICEL, DNA AND RNA INFECTIONS QUECODIFY SUCH PROTEIN; EXPRESSION VECTORS AND RECOMBINANT MICROORGANISMS THAT INCLUDE SUCH DNA OR RNA; VACCINE COMPOSITIONS THAT INCLUDE DICH - Google Patents
USEFUL FUSION PROTEIN IN THE TREATMENT OR PREVENTION OF ZOSTER HERPES AND IN THE PREVENTION OR TREATMENT OF VARICEL, DNA AND RNA INFECTIONS QUECODIFY SUCH PROTEIN; EXPRESSION VECTORS AND RECOMBINANT MICROORGANISMS THAT INCLUDE SUCH DNA OR RNA; VACCINE COMPOSITIONS THAT INCLUDE DICHInfo
- Publication number
- AR027484A1 AR027484A1 ARP000100224A ARP000100224A AR027484A1 AR 027484 A1 AR027484 A1 AR 027484A1 AR P000100224 A ARP000100224 A AR P000100224A AR P000100224 A ARP000100224 A AR P000100224A AR 027484 A1 AR027484 A1 AR 027484A1
- Authority
- AR
- Argentina
- Prior art keywords
- rna
- dna
- treatment
- prevention
- protein
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108020001507 fusion proteins Proteins 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 2
- 101100331550 Antirrhinum majus DICH gene Proteins 0.000 title 1
- 208000007514 Herpes zoster Diseases 0.000 title 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title 1
- 239000013604 expression vector Substances 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Una proteína de fusion que comprende (1) una proteína gE del virus de la varicela Zoster o un fragmento inmunologicamente activo de la misma fusionados a(2) una proteína diferente del virus de la Varicela Zoster o un fragmento inmunologicamente activ o de la misma. También se propone el ADN y/o ARN y vectoresrecombinantes que codifican dicha proteína y composiciones de vacuna formuladas con dichas proteínas de aplicacion para el tratamiento de pacientes afectados osusceptibles de ser afectados po r infecciones o recurrencias del virus de la varicela zoster.A fusion protein comprising (1) a varicella Zoster virus gE protein or an immunologically active fragment thereof fused to (2) a different protein from Varicella Zoster virus or an immunologically active fragment thereof. It is also proposed the DNA and / or RNA and recombinant vectors encoding said protein and vaccine compositions formulated with said application proteins for the treatment of patients affected or susceptible to being affected by infections or recurrences of the varicella zoster virus.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9901254.4A GB9901254D0 (en) | 1999-01-20 | 1999-01-20 | Vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027484A1 true AR027484A1 (en) | 2003-04-02 |
Family
ID=10846213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000100224A AR027484A1 (en) | 1999-01-20 | 2000-01-18 | USEFUL FUSION PROTEIN IN THE TREATMENT OR PREVENTION OF ZOSTER HERPES AND IN THE PREVENTION OR TREATMENT OF VARICEL, DNA AND RNA INFECTIONS QUECODIFY SUCH PROTEIN; EXPRESSION VECTORS AND RECOMBINANT MICROORGANISMS THAT INCLUDE SUCH DNA OR RNA; VACCINE COMPOSITIONS THAT INCLUDE DICH |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR027484A1 (en) |
AU (1) | AU2292600A (en) |
CO (1) | CO5241364A1 (en) |
GB (1) | GB9901254D0 (en) |
WO (1) | WO2000043527A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0504436D0 (en) * | 2005-03-03 | 2005-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
AU2012213948B2 (en) * | 2005-03-03 | 2016-01-21 | Glaxosmithkline Biologicals S.A. | Vaccine |
CA2729011A1 (en) * | 2007-07-19 | 2009-01-22 | Novavax, Inc. | Varicella zoster virus-virus like particles (vlps) and antigens |
EP2670443A4 (en) * | 2011-01-31 | 2015-10-14 | Univ Pennsylvania | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof |
KR101723605B1 (en) * | 2014-10-21 | 2017-04-07 | 진원생명과학 주식회사 | Dna vaccine composition for preventing and treating herpes zoster and method of activating t-cell to vzv antizen by using the same |
WO2018097642A1 (en) * | 2016-11-25 | 2018-05-31 | 재단법인 목암생명과학연구소 | Varicella zoster virus vaccine |
KR102028463B1 (en) * | 2016-11-25 | 2019-10-04 | 재단법인 목암생명과학연구소 | Varicella Zoster Virus Vaccines |
CN112142828B (en) * | 2019-06-28 | 2022-02-01 | 怡道生物科技(苏州)有限公司 | gE gene and vector for expressing the gene |
EP4074335A4 (en) * | 2019-12-13 | 2024-09-04 | Grand Theravac Life Science Nanjing Co Ltd | Immunostimulatory composition and use thereof |
CN115819616A (en) * | 2021-07-28 | 2023-03-21 | 江苏瑞科生物技术股份有限公司 | Gene recombination VZV fusion protein and preparation method and application thereof |
MX2024006407A (en) | 2021-11-24 | 2024-08-19 | Flagship Pioneering Innovations Vi Llc | Varicella-zoster virus immunogen compositions and their uses. |
CN114891830B (en) * | 2022-04-02 | 2024-03-01 | 武汉博沃生物科技有限公司 | Recombinant expression vector based on varicella-zoster virus, recombinant virus and application thereof |
WO2024153235A1 (en) * | 2023-01-19 | 2024-07-25 | 厦门大学 | Fusion protein of ge and gi of varicella-zoster virus and use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69017769T2 (en) * | 1989-06-27 | 1995-07-13 | Smithkline Beecham Biologicals S.A., Rixensart | Links. |
GB9226768D0 (en) * | 1992-12-23 | 1993-02-17 | Smithkline Beecham Biolog | Vaccines |
GB9413751D0 (en) * | 1994-07-07 | 1994-08-24 | British Bio Technology | Immunodominant peptides |
CZ289971B6 (en) * | 1996-02-09 | 2002-05-15 | Smithkline Beecham Biologicals S. A. | Pharmaceutical preparation against product of gene 63 Varicella Zoster |
-
1999
- 1999-01-20 GB GBGB9901254.4A patent/GB9901254D0/en not_active Ceased
-
2000
- 2000-01-17 WO PCT/EP2000/000352 patent/WO2000043527A1/en active Search and Examination
- 2000-01-17 AU AU22926/00A patent/AU2292600A/en not_active Abandoned
- 2000-01-18 AR ARP000100224A patent/AR027484A1/en unknown
- 2000-01-20 CO CO00002923A patent/CO5241364A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB9901254D0 (en) | 1999-03-10 |
AU2292600A (en) | 2000-08-07 |
CO5241364A1 (en) | 2003-01-31 |
WO2000043527A1 (en) | 2000-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR027484A1 (en) | USEFUL FUSION PROTEIN IN THE TREATMENT OR PREVENTION OF ZOSTER HERPES AND IN THE PREVENTION OR TREATMENT OF VARICEL, DNA AND RNA INFECTIONS QUECODIFY SUCH PROTEIN; EXPRESSION VECTORS AND RECOMBINANT MICROORGANISMS THAT INCLUDE SUCH DNA OR RNA; VACCINE COMPOSITIONS THAT INCLUDE DICH | |
ECSP093601A (en) | PROTEINS DERIVED FROM THE WHITE SPOT SYNDROME VIRUS AND ITS USES | |
DK0587780T4 (en) | Infectious agent that causes Mystery Swine Disease, vaccine preparations and diagnostic kits | |
ES2140418T3 (en) | CHEMICAL FLAVIVIRUS AND / OR RESTRICTED GROWTH FLAVIVIRUS. | |
ATE270342T1 (en) | ENDOSOMOLYTIC PARTICLES | |
IL150571A0 (en) | Novel chimeric proteins and methods for using the same | |
ES2054601T3 (en) | PROTEIN WITH CYTOKINE TYPE ACTIVITY, RECOMBINANT DNA CODE FOR THIS PROTEIN, CELLS AND TRANSFORMED MICROORGANISMS. | |
DK1349944T3 (en) | Latency-associated peptide of TGF-beta to confer latency to pharmaceutically active proteins | |
EA200400962A1 (en) | POLYALKYLENE GLYCOL WITH RESIDUAL FOR CONJUGATION OF BIOLOGICALLY ACTIVE CONNECTION | |
BR0107703A (en) | Recombinant flaviviruses and processes for their use | |
ES2146214T3 (en) | VACCINES FOR ACTINOBACILLUS PLEUROPNEUMONIAE. | |
AR029644A1 (en) | ISOLATED PROTEIN, ISOLATED POLINUCLEOTIDE, TRANSGENIC GUEST CELL, METHOD FOR CONTROLLING A NON-MAMMAL PEST, BIOLOGICALLY PURE CULTURE | |
FI860445A0 (en) | PARVOVIRUS VACCIN FOER HUND. | |
ES2137310T3 (en) | VACCINE AGAINST STREPTOCOCCUS SUIS INFECTION. | |
BR9803960A (en) | D-sorbitol dehydrogenase gene. | |
AR042968A1 (en) | ANTI-DENGUE VIRUS ANTIBODIES COMPOSITIONS METHODS AND USES | |
BR112022026248A2 (en) | CYTOKINE CONJUGATES | |
AR005750A1 (en) | PHARMACEUTICAL COMPOSITION TO TREAT OR PREVENT ZOSTER INFECTIONS IN PERSONS INFECTED WITH THE VARICELA ZOSTER VIRUS AND PROCEDURE FOR PREPARING SUCH COMPOSITION | |
DK1417222T3 (en) | Isolated polypeptides based on the neutralizing epitope of the p17 protein from HIV suitable for vaccines as well as neutralizing anti-p17 antibodies that specifically recognize said neutralizing epitope | |
DK0918865T3 (en) | Immunologically active proteins of Borrelia burgdorferi, therefore coding nucleic acids and their use in test kits and as vaccines | |
PE20001287A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING DNA FRAGMENTS ENCODING AN ANTIGENIC PROTEIN WITH ANTITUMORAL EFFECT | |
AR028713A1 (en) | IMMUNIZATION OF MILK-PRODUCED LIVESTOCK WITH CHEMERIC GAPC PROTEINS AGAINST STREPTOCOCCUS INFECTIONS | |
ES2136062T3 (en) | PLASMID PCTD ISOLATED FROM CHLAMYDIA TRACHOMATIS SEROTYPE D, GENES AND PROTEINS CODED BY THE SAME; RECOMBINANT PLASMIDS FOR THE EXPRESSION OF SUCH GENES IN HETEROLOGICAL SYSTEMS AS RECOMBINANT FUSION PROTEINS, PREPARATION OF SUCH RECOMBINANT PROTEINS AND ... | |
WO2001055353A3 (en) | Recombinant attenuation of prrsv | |
BR0010222A (en) | Viral Expression Vectors |